Quarterly data report: Q1 2020

Monthly data report: March 2020

Innovative region: Spain

Sector report: Consumer

Pupil, developer of a spatial analysis system for real estate, raised $16.1m in a round led by property developer City Developments that will fund product development.

North Wearables, the Intel and Amazon-backed AR glasses developer formerly known as Thalmic Labs, has raised $170m over eight years but could run out of cash within four months.

Monthly analysis: February 2020

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Pfizer and Lundbeck scored exits as blood-disease therapy developer Imara raised $75.2m, floating at the foot of its range.

HTC Vive is set to exit VR product design platform developer Mindesk after investing in its seed round early last year.

The university has put together a $1m fund for health-oriented participants in its Velocity accelerator competition.

CRM app developer Vlocity had received $163m from investors including Salesforce itself as well as fellow corporates New York Life and Accenture.

Returning investor RATP Capital Innovation and long-term insurer Allianz France both participated as the moped rental platform raised $25.5m.

Samsung Venture Investment has invested in train ticketing portal RailYatri's bus spinoff, IntrCity, as part of a $13.5m round.

The sickle cell disease drug developer, which is backed by Pfizer Ventures and Lundbeckfonden Ventures, has filed for an $86.3m IPO.

Wipro Ventures was given an exit from email security software developer Emailage, which was acquired by LexisNexis Risk Solutions. The sizeable exit is part of the wider cybersecurity space, which has received much attention by corporates over the past decade.

The Mastercard-backed customer service bot developer took its total funding past $50m with $7m from Napier Park Financial Partners.

The educational app developer, which counts Tencent, Naspers and BCC among its investors, raised the money at a valuation of about $8bn.

Galecto, whose investors include Novo, Merck Group and Bristol-Myers Squibb, is merging with Celgene-backed PharmAkea, with the joint entity retaining the Galecto name and leadership team.

Grain-industry data management platform Bushel secured $19.5m from Continental Grain among others to take its total funding to $28m.